← back to search

Kuan‐Hsiang Gary Huang

Johnson & Johnson (United States) · US
Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, HIV Research and Treatment, and T-cell and B-cell Immunology.
h-index
14
citations
927
works
58
NIH funding
primary concept
Medicine
email

Recent publications

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
The Lancet 2024cited by 75position: middledoi
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
Gastroenterology 2023cited by 90position: middledoi
HIV Control through a Single Nucleotide on the HLA-B Locus
Journal of Virology 2012cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Henrik N. Kløverpris · LEO Foundation1 papers (2012–2012) · 1 papers (2012–2012)Søren Buus · University of Copenhagen1 papers (2012–2012)Mary Carrington · Cancer Institute (WIA)1 papers (2012–2012)Bruce D. Walker · Active Technologies (Italy)1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012)Jonathan M. Carlson · National Institute of Allergy and Infectious Diseases1 papers (2012–2012)Fabian Chen · UNSW Sydney1 papers (2012–2012)Dominique Goedhals · National Health Laboratory Service1 papers (2012–2012)Thumbi Ndung’u · Africa Health Research Institute1 papers (2012–2012)Philip Goulder · Ragon Institute of MGH, MIT and Harvard1 papers (2012–2012)John Frater · University of Oxford1 papers (2012–2012) · 1 papers (2012–2012)Cloete van Vuuren · London School of Hygiene & Tropical Medicine1 papers (2012–2012)Alasdair Leslie · Kansas State University1 papers (2012–2012) · 1 papers (2012–2012)